IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

Patients with metastatic or recurrent and refractory sarcomas have a dismal prognosis. Therefore, new targeted therapies are urgently needed. This study was designed to evaluate chimeric antigen receptor (CAR) T cells targeting the type I insulin-like growth factor receptor (IGF1R) or tyrosine kinas...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xin, Park, Haein, Greene, Joseph, Pao, James, Mulvey, Erin, Zhou, Sophia X., Albert, Catherine M., Moy, Fred, Sachdev, Deepali, Yee, Douglas, Rader, Christoph, Hamby, Carl V., Loeb, David M., Cairo, Mitchell S., Zhou, Xianzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501840/
https://www.ncbi.nlm.nih.gov/pubmed/26173023
http://dx.doi.org/10.1371/journal.pone.0133152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501840/
https://www.ncbi.nlm.nih.gov/pubmed/26173023
http://dx.doi.org/10.1371/journal.pone.0133152

Ejemplares similares